A highly sensitive nanobody-based immunoassay detecting SARS-CoV-2 nucleocapsid protein using all-recombinant reagents.

Front Immunol · 2023 · PMC10367427 · PMID 37497229

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Although this difference was less pronounced than we had anticipated based on previous reports ( 30 ), the analysis of nasopharyngeal swab samples using the luminescent assay showed a highly significant improvement in the clinical performance of the test.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.